EZZ Life Science Holdings Ltd Total Liabilities

Latest as of December 2025: AU$4.80 Million AUD ≈ $3.39 Million USD

EZZ Life Science Holdings Ltd total liabilities. Based on the latest financial reports, EZZ Life Science Holdings Ltd (EZZ) has total liabilities worth AU$4.80 Million AUD (≈ $3.39 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EZZ asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of EZZ Life Science Holdings Ltd (2017–2024)

Total liabilities of EZZ Life Science Holdings Ltd from 2017 to 2024. This chart illustrates how EZZ Life Science Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data.

EZZ Life Science Holdings Ltd Competitors by Total Liabilities

The table below lists competitors of EZZ Life Science Holdings Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
ABM Fujiya Bhd KLSE:5198	Malaysia	RM379.24 Million
Palatin Technologies, Inc. Common Stock NASDAQ:PTN	USA	$2.63 Million
Nexen Corp KO:005725	Korea	₩3.20 Trillion
Cahayaputra Asa Keramik Tbk PT JK:CAKK	Indonesia	Rp326.94 Billion
Seamless Distribution Systems AB ST:SDS	Sweden	Skr339.60 Million
Yonga Mobilya Sanayi ve Ticaret AS IS:YONGA	Turkey	TL36.37 Million
Prairie Provident Resources Inc TO:PPR	Canada	CA$174.93 Million
GlycoMimetics Inc NASDAQ:GLYC	USA	$2.62 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down EZZ Life Science Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see EZZ Life Science Holdings Ltd asset portfolio.

Liquidity & Leverage Metrics

EZZ Life Science Holdings Ltd Total Liabilities Ratios Explained

EZZ Life Science Holdings Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	6.57	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.17	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EZZ Life Science Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EZZ Life Science Holdings Ltd (2017–2024)

The table below shows the annual total liabilities of EZZ Life Science Holdings Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$5.87 Million ≈ $4.15 Million	+38.83%
2023-12-31	AU$4.23 Million ≈ $2.99 Million	+38.28%
2022-12-31	AU$3.06 Million ≈ $2.16 Million	+6.27%
2021-12-31	AU$2.88 Million ≈ $2.04 Million	+49.05%
2020-12-31	AU$1.93 Million ≈ $1.37 Million	-48.86%
2019-12-31	AU$3.78 Million ≈ $2.67 Million	+80.61%
2018-12-31	AU$2.09 Million ≈ $1.48 Million	--
2017-12-31	AU$0.00 ≈ $0.00	--

About EZZ Life Science Holdings Ltd

AU:EZZ Australia Biotechnology

Market Cap

$10.15 Million

AU$14.35 Million AUD

Market Cap Rank

#26877 Global

#1241 in Australia

Share Price

AU$0.31

Change (1 day)

+0.00%

52-Week Range

AU$0.30 - AU$2.52

All Time High

AU$4.93